Results 101 to 110 of about 48,609 (121)

Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease. [PDF]

Front Cardiovasc Med
Guo J, Wu Y, Wan Z, Zhang Z.
europepmc   +1 more source

p53: The Multifaceted Roles of Covalent Modifications in Cancer. [PDF]

Pharmaceuticals (Basel)
Grigoreva TA, Romanova AA, Tribulovich VG, Pestov NB, Oganov RA, Kovaleva DK, Korneenko TV, Barlev NA.   +7 more
europepmc   +1 more source

Conventional and Alternative B Lymphopoiesis: Multiple Roads to Immunity. [PDF]

Stem Cell Rev Rep
Chiron-Margerie A, Bessoles S, Sarrabayrouse G, Krzysiek R, Hacein-Bey-Abina S.   +4 more
europepmc   +1 more source

Analysis of data on biosimilar prescription rates in rheumatology practice from a reference center in Turkey. [PDF]

Sci Rep
Kaplan H, Cengiz G, Kara H, Cüce İ, Kirnap M, Çaliş M.   +5 more
europepmc   +1 more source

Ribosome dysregulation and intervention in age-related infertility. [PDF]

Cell Rep Med
Li J, Wang H, Zhu P, Chen H, Zuo H, Liu C, Liu L, Ye X, Feng G, Wu Y, Liu Q, Yang T, Keefe DL, Bai X, Shang W, Wu X, Liu L.   +16 more
europepmc   +1 more source

Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam. [PDF]

PLoS One
Matusin SNI, Mumin N, Zainal Abidin H, Mohd Jaya FN, Lu ZH, Haji Abdul Hamid MRW.   +5 more
europepmc   +1 more source

Clinical, Metabolic, and Autoimmune Characteristics of Newly Diagnosed Young Filipino Adults with Diabetes Mellitus. [PDF]

Acta Med Philipp
Paz-Pacheco E, Uy ABC, Tiglao-Gica AL, Arcellana AES, Dayo-Lacdao AB, Cordero CP, Jimeno CA, Añonuevo-Cruz MC, Juban NR, Young DM Research Group*.   +9 more
europepmc   +1 more source

Simultaneous improvement of breast muscle yield and meat quality in Langshan chickens. [PDF]

Poult Sci
Chen J, Zhang X, Zhang L, Xing T, Gao F, Zhao L.   +5 more
europepmc   +1 more source

Enhancing PARP inhibitor efficacy in ovarian cancer: targeting the PI3K/AKT/mTOR pathway. [PDF]

J Ovarian Res
Wang Y, Xia Q, Wang X, Lu Y, Wang S, Jiao Y.   +5 more
europepmc   +1 more source

The mechanism of the PI3K-AKT-mTOR signaling pathway in renal cell carcinoma: current developments and future prospects. [PDF]

Front Oncol
Zou C, Wang Y, Chen Q, Shi J, Wu X, Luo Q.   +5 more
europepmc   +1 more source